Endometrial cancer: A review and current management strategies: Part i

Gynecologic Oncology

Volumn 134, Issue 2, 2014, Pages 385-392

  Burke, William M ^a,b   Orr, James ^c   Leitao, Mario ^d   Salom, Emery ^e   Gehrig, Paola ^f   Olawaiye, Alexander B ^g   Brewer, Molly ^h   Boruta, Dave ⁱ   Villella, Jeanine ^j,k   Herzog, Tom ^b   Abu Shahin, Fadi ^c  

^a One Valley Health Plaza   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Florida Society of Gynecologic Oncologists   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j WINTHROP UNIVERSITY HOSPITAL   (United States)

^k STONY BROOK UNIVERSITY   (United States)

more..

Author keywords

Diagnosis; Endometrial cancer; Evaluation; Review; Risk factors; Surgery

Indexed keywords

DIAGNOSIS; ENDOMETRIAL CANCER; EVALUATION; REVIEW; RISK FACTORS; SURGERY;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS;

EID: 84905583859     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.05.018     Document Type: Review

References (73)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 2013 11 30
2. H. Jick, A.M. Walker, and K.J. Rothman The epidemic of endometrial cancer: a commentary Am J Public Health 70 3 1980 264 267
3. K.E. Oliver et al. Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment Gynecol Oncol 123 1 2011 76 81
4. M.C. Pike et al. Estrogen-progestin replacement therapy and endometrial cancer J Natl Cancer Inst 89 15 1997 1110 1116
5. S. Shapiro et al. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens N Engl J Med 313 16 1985 969 972
6. B. Fisher et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 J Natl Cancer Inst 86 7 1994 527 537
7. A.G. Renehan et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 2008 569 578
8. P.T. Soliman et al. Association between adiponectin, insulin resistance, and endometrial cancer Cancer 106 11 2006 2376 2381
9. M. Soler et al. Hypertension and hormone-related neoplasms in women Hypertension 34 2 1999 320 325
10. D.G. Gallup, and R.J. Stock Adenocarcinoma of the endometrium in women 40 years of age or younger Obstet Gynecol 64 3 1984 417 420
11. P.T. Soliman et al. Risk factors for young premenopausal women with endometrial cancer Obstet Gynecol 105 3 2005 575 580
12. C.P. McPherson et al. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study Am J Epidemiol 143 12 1996 1195 1202
13. B. Zhou et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis Am J Med 121 6 2008 501 508 [e3]
14. V. Bonadona et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome JAMA 305 22 2011 2304 2310
15. X.P. Zhou et al. Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors Hum Mol Genet 11 4 2002 445 450
16. C. Eng PTEN: one gene, many syndromes Hum Mutat 22 3 2003 183 198
17. D.A. Levine et al. Risk of endometrial carcinoma associated with BRCA mutation Gynecol Oncol 80 3 2001 395 398
18. A. Timmermans et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis Obstet Gynecol 116 1 2010 160 167
19. F.P. Dijkhuizen et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis Cancer 89 8 2000 1765 1772
20. E. Epstein et al. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding Acta Obstet Gynecol Scand 80 12 2001 1131 1136
21. D.O. Lee, M.H. Jung, and H.Y. Kim et al. Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding J Obstet Gynaecol Res 2011
22. H. Hricak et al. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study Radiology 179 3 1991 829 832
23. J.P. Connor et al. Computed tomography in endometrial carcinoma Obstet Gynecol 95 5 2000 692 696
24. K. Kitajima et al. Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer Eur Radiol 19 6 2009 1529 1536
25. M. Signorelli et al. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases Gynecol Oncol 115 2 2009 231 235
26. J.Y. Park et al. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer Gynecol Oncol 108 3 2008 486 492
27. N. Bansal et al. The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies Gynecol Oncol 111 2 2008 208 212
28. C.H. Hsieh et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86 1 2002 28 33
29. J.T. Soper et al. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma Am J Obstet Gynecol 163 4 Pt 1 1990 1204 1209
30. A.B. Olawaiye et al. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma Gynecol Oncol 110 3 2008 293 298
31. W.T. Creasman et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 8 Suppl. 1987 2035 2041
32. J.M. Childers et al. Laparoscopically assisted surgical staging (LASS) of endometrial cancer Gynecol Oncol 51 1 1993 33 38
33. N.M. Spirtos et al. Laparoscopic bilateral pelvic and paraaortic lymph node sampling: an evolving technique Am J Obstet Gynecol 173 1 1995 105 111
34. J.L. Walker et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 J Clin Oncol 27 32 2009 5331 5336
35. A.B. Kornblith et al. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study J Clin Oncol 27 32 2009 5337 5342
36. S. Palomba et al. Updating of a recent meta-analysis of randomized controlled trials to assess the safety and the efficacy of the laparoscopic surgery for treating early stage endometrial cancer Gynecol Oncol 114 1 2009 135 136
37. J.L. Walker et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study J Clin Oncol 30 7 2012 695 700
38. J.F. Boggess et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy Am J Obstet Gynecol 199 4 2008 360 [e1-9]
39. L.G. Seamon et al. Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer Obstet Gynecol 112 6 2008 1207 1213
40. P.A. Gehrig et al. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Gynecol Oncol 111 1 2008 41 45
41. M.C. Bell et al. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques Gynecol Oncol 111 3 2008 407 411
42. O. Zivanovic et al. The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease Gynecol Oncol 111 3 2008 431 437
43. A. Martinez et al. Low incidence of port-site metastases after laparoscopic staging of uterine cancer Gynecol Oncol 118 2 2010 145 150
44. R. Berretta et al. Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population Int J Gynecol Cancer 18 4 2008 797 802
45. G. Massi, L. Savino, and T. Susini Vaginal hysterectomy versus abdominal hysterectomy for the treatment of stage I endometrial adenocarcinoma Am J Obstet Gynecol 174 4 1996 1320 1326
46. T. Susini et al. Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly Gynecol Oncol 96 2 2005 362 367
47. L.C. Kilgore et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling Gynecol Oncol 56 1 1995 29 33
48. A. Mariani et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging Gynecol Oncol 109 1 2008 11 18
49. N.R. Abu-Rustum et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes Gynecol Oncol 115 2 2009 236 238
50. N.R. Abu-Rustum et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol 113 2 2009 163 169
51. F. Khoury-Collado et al. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes Gynecol Oncol 122 2 2011 251 254
52. S.C. Dowdy et al. Extra-peritoneal laparoscopic para-aortic lymphadenectomy - a prospective cohort study of 293 patients with endometrial cancer Gynecol Oncol 111 3 2008 418 424
53. H.M. Keys et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 3 2004 744 751
54. N.R. Abu-Rustum et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center Gynecol Oncol 103 2 2006 714 718
55. Y. Todo et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy Gynecol Oncol 119 1 2010 60 64
56. J.M. Cragun et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer J Clin Oncol 23 16 2005 3668 3675
57. E.L. Trimble, C. Kosary, and R.C. Park Lymph node sampling and survival in endometrial cancer Gynecol Oncol 71 3 1998 340 343
58. Y. Todo et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 9721 2010 1165 1172
59. C.V. Lutman et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology Gynecol Oncol 102 1 2006 92 97
60. J.K. Chan et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients Cancer 107 8 2006 1823 1830
61. P. Benedetti Panici et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 23 2008 1707 1716
62. H. Kitchener et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 9658 2009 125 136
63. W.T. Creasman, D.E. Mutch, and T.J. Herzog ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol 116 3 2010 293 294
64. M. Ballester et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) Lancet Oncol 12 5 2011 469 476
65. S. Percorelli, C.W. Pettersson, F. Benedet, and J.L. Sharperd FIGO annual report on the results of treatment in gynecologic cancer J Epidemiol Biostat 3 35 1998 35 62
66. K.K. Shih et al. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma Gynecol Oncol 122 3 2011 608 611
67. N.C. Lambrou et al. Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival Gynecol Oncol 93 3 2004 653 658
68. B.A. Goff et al. Surgical stage IV endometrial carcinoma: a study of 47 cases Gynecol Oncol 52 2 1994 237 240
69. R.E. Bristow et al. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival Gynecol Oncol 78 2 2000 85 91
70. E. Campagnutta et al. Surgical treatment of recurrent endometrial carcinoma Cancer 100 1 2004 89 96
71. S.C. Dowdy et al. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes Gynecol Oncol 101 2 2006 280 286
72. R.E. Bristow et al. Salvage cytoreductive surgery for recurrent endometrial cancer Gynecol Oncol 103 1 2006 281 287
73. R.R. Barakat et al. Pelvic exenteration for recurrent endometrial cancer Gynecol Oncol 75 1 1999 99 102